Neuromodulation Pioneer WISE Closes EUR 15M Series C Financing Round to Launch Second Product, SCS EXPERT, for Chronic Pain
Neuromodulation Pioneer WISE Closes EUR 15M Series C Financing Round to Launch Second Product, SCS EXPERT, for Chronic Pain
10/01/20, 7:08 AM
Location
londonRound Type
series c
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, today announced the closing of a EUR 15 million Series C financing round. New investors, led by CDP Venture Capital SGR, and including Indaco Ventures I Fund and EUREKA! Venture SGR, joined existing investors participating in this round – Principia SGR, New Frontier, Atlante Seed and Atlante Ventures (funds managed by Indaco Venture Partners SGR), High Tech Gründerfonds and F3F.
Company Info
Location
london, ontario, canada
Additional Info
WISE develops and manufactures a new generation of biocompatible, foldable, stretchable and minimally invasive implantable leads for Neuromodulation and Neuromonitoring for the treatment of Chronic Pain and for pre-surgical Epilepsy monitoring.